Fig. 4From: The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patientsMaximum FO (MFO) during ICU stay in N-AKI, AKI and AKI-RRT patients. MFO was higher in patients with AKI and particularly high in those treated with RRT. The horizontal axis shows the median day when MFO occurred. AKI patients with acute kidney injury, AKI-RRT patients with acute kidney injury treated with renal replacement therapy, N-AKI patients without AKIBack to article page